share_log

Xilio Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner GILEAD SCIENCES, INC.

SEC announcement ·  Apr 3 18:54
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more